Resultados de procura - Shervin Assassi

Limitar resultados
  1. 1
    The Role of Type 1 Interferon in Systemic Sclerosis

    The Role of Type 1 Interferon in Systemic Sclerosis por Minghua Wu, Shervin Assassi

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?

    Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity? por Chandra Mohan, Shervin Assassi

    Publicado 2015
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Type I interferon dysregulation in Systemic Sclerosis

    Type I interferon dysregulation in Systemic Sclerosis por Brian Skaug, Shervin Assassi

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need

    Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need por Ariane L. Herrick, Shervin Assassi, Christopher P. Denton

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  5. 5
    Genetics of scleroderma: implications for personalized medicine?

    Genetics of scleroderma: implications for personalized medicine? por Shervin Assassi, Timothy R. D. J. Radstake, Maureen D. Mayes, Javier Martı́n

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  6. 6
    Role of STAT3 in skin fibrosis and transforming growth factor beta signalling

    Role of STAT3 in skin fibrosis and transforming growth factor beta signalling por Mesias Pedroza, Sarah To, Shervin Assassi, Minghua Wu, David J. Tweardy, Sandeep K. Agarwal

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culprit

    Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culprit por Vishal Kakkar, Shervin Assassi, Yannick Allanore, Masataka Kuwana, Christopher P. Denton, Dinesh Khanna, Francesco Del Galdo

    Publicado 2022
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  8. 8
    Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis

    Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis por John D Pauling, Gloria A. Salazar, Hui Lu, Zoë Betteridge, Shervin Assassi, Maureen D. Mayes, Neil McHugh

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Deep Learning Classification of Systemic Sclerosis Skin Using the MobileNetV2 Model

    Deep Learning Classification of Systemic Sclerosis Skin Using the MobileNetV2 Model por Metin Akay, Yong Du, Cheryl L. Sershen, Minghua Wu, Ting Y. Chen, Shervin Assassi, Chandra Mohan, Yasemin M. Akay

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Does C‐Reactive Protein Predict the Long‐Term Progression of Interstitial Lung Disease and Survival in Patients With Early Systemic Sclerosis?

    Does C‐Reactive Protein Predict the Long‐Term Progression of Interstitial Lung Disease and Survival in Patients With Early Systemic Sclerosis? por Xiaochun Liu, Maureen D. Mayes, Claudia Pedroza, Hilda T. Draeger, Emilio B. González, Brock E. Harper, John D. Reveille, Shervin Assassi

    Publicado 2013
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    KL-6 But Not CCL-18 Is a Predictor of Early Progression in Systemic Sclerosis-related Interstitial Lung Disease

    KL-6 But Not CCL-18 Is a Predictor of Early Progression in Systemic Sclerosis-related Interstitial Lung Disease por Gloria A. Salazar, Masataka Kuwana, Minghua Wu, Rosa M. Estrada‐Y‐Martin, Binwu Ying, Julio Charles, Maureen D. Mayes, Shervin Assassi

    Publicado 2018
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Osteopontin in Systemic Sclerosis and Its Role in Dermal Fibrosis

    Osteopontin in Systemic Sclerosis and Its Role in Dermal Fibrosis por Minghua Wu, Daniel J. Schneider, Maureen D. Mayes, Shervin Assassi, Frank C. Arnett, Filemon K. Tan, Michael R. Blackburn, Sandeep K. Agarwal

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Identification of Cadherin 11 as a Mediator of Dermal Fibrosis and Possible Role in Systemic Sclerosis

    Identification of Cadherin 11 as a Mediator of Dermal Fibrosis and Possible Role in Systemic Sclerosis por Minghua Wu, Mesias Pedroza, Robert Lafyatis, A. J. George, Maureen D. Mayes, Shervin Assassi, Filemon K. Tan, Michael B. Brenner, Sandeep K. Agarwal

    Publicado 2013
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Correlation of interferon‐inducible chemokine plasma levels with disease severity in systemic sclerosis

    Correlation of interferon‐inducible chemokine plasma levels with disease severity in systemic sclerosis por Xiaochun Liu, Maureen D. Mayes, Filemon K. Tan, Minghua Wu, John D. Reveille, Brock E. Harper, Hilda T. Draeger, Emilio B. González, Shervin Assassi

    Publicado 2012
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Right Bundle Branch Block: A Predictor of Mortality in Early Systemic Sclerosis

    Right Bundle Branch Block: A Predictor of Mortality in Early Systemic Sclerosis por Hilda T. Draeger, Shervin Assassi, Roozbeh Sharif, Emilio B. González, Brock E. Harper, Frank C. Arnett, Ameena Manzoor, Richard A. Lange, Maureen D. Mayes

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations

    Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations por Pravitt Gourh, Frank C. Arnett, Shervin Assassi, Filemon K. Tan, Mei Huang, Laura Diekman, Maureen D. Mayes, John D. Reveille, Sandeep K. Agarwal

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    A one‐year, phase I/IIa, open‐label pilot trial of imatinib mesylate in the treatment of systemic sclerosis–associated active interstitial lung disease

    A one‐year, phase I/IIa, open‐label pilot trial of imatinib mesylate in the treatment of systemic sclerosis–associated active interstitial lung disease por Dinesh Khanna, Rajeev Saggar, Maureen D. Mayes, Fereidoun Abtin, Philip J. Clements, Paul Maranian, Shervin Assassi, Rajan Saggar, Ram Raj Singh, Daniel E. Furst

    Publicado 2011
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis

    Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis por Rajpreet K. Arora-Singh, Shervin Assassi, Deborah J. del Junco, Frank C. Arnett, Marilyn Perry, Uzma Irfan, Roozbeh Sharif, Tony Mattar, Maureen D. Mayes

    Publicado 2010
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects

    Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects por S. Hoa, Marie Hudson, Yves Troyanov, S. Proudman, Jenny Walker, Wendy Stevens, M. Nikpour, Shervin Assassi, Maureen D. Mayes, M. Wang, Murray Baron, M J Fritzler

    Publicado 2016
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Psychological correlates of self-reported functional limitation in patients with ankylosing spondylitis

    Psychological correlates of self-reported functional limitation in patients with ankylosing spondylitis por Tamar F Brionez, Shervin Assassi, John D. Reveille, Thomas J. Learch, Laura Diekman, Michael M. Ward, John C. Davis, Michael H. Weisman, Perry M. Nicassio

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: